Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenoviridae | 5 | 2007 | 1100 | 0.780 |
Why?
|
| Cell Hypoxia | 4 | 2005 | 675 | 0.570 |
Why?
|
| Integrative Medicine | 2 | 2016 | 87 | 0.500 |
Why?
|
| Hypoxia-Inducible Factor 1 | 4 | 2007 | 198 | 0.440 |
Why?
|
| Oncolytic Viruses | 2 | 2007 | 327 | 0.420 |
Why?
|
| Virus Replication | 5 | 2005 | 2535 | 0.390 |
Why?
|
| Oncolytic Virotherapy | 2 | 2007 | 498 | 0.370 |
Why?
|
| Genetic Vectors | 4 | 2004 | 3421 | 0.360 |
Why?
|
| Complementary Therapies | 1 | 2012 | 485 | 0.310 |
Why?
|
| Low Back Pain | 3 | 2012 | 956 | 0.310 |
Why?
|
| Dibenzothiazepines | 1 | 2007 | 103 | 0.280 |
Why?
|
| Glioma | 4 | 2004 | 3401 | 0.260 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2004 | 76 | 0.250 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1147 | 0.230 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2419 | 0.210 |
Why?
|
| Drug Resistance | 1 | 2007 | 1606 | 0.190 |
Why?
|
| Patient Care Team | 1 | 2012 | 2528 | 0.190 |
Why?
|
| Violence | 1 | 2007 | 909 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2004 | 5854 | 0.170 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 743 | 0.160 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9648 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2004 | 627 | 0.140 |
Why?
|
| Brain Neoplasms | 3 | 2004 | 8856 | 0.120 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 3057 | 0.110 |
Why?
|
| Neoplasms | 5 | 2005 | 21675 | 0.110 |
Why?
|
| Duty to Warn | 1 | 1992 | 30 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 4 | 2004 | 6311 | 0.100 |
Why?
|
| Psychotic Disorders | 1 | 2007 | 3044 | 0.100 |
Why?
|
| Jurisprudence | 1 | 1992 | 110 | 0.100 |
Why?
|
| Social Control, Formal | 1 | 1992 | 110 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2004 | 12209 | 0.100 |
Why?
|
| Law Enforcement | 1 | 1992 | 109 | 0.090 |
Why?
|
| Gentamicins | 1 | 1991 | 255 | 0.090 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 1009 | 0.090 |
Why?
|
| Confidentiality | 1 | 1992 | 613 | 0.070 |
Why?
|
| Manipulation, Chiropractic | 1 | 2007 | 22 | 0.070 |
Why?
|
| Massage | 1 | 2007 | 85 | 0.070 |
Why?
|
| HIV Seropositivity | 1 | 1992 | 971 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2760 | 0.070 |
Why?
|
| Disclosure | 1 | 1992 | 737 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 8430 | 0.070 |
Why?
|
| Carmustine | 1 | 2004 | 137 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1722 | 0.060 |
Why?
|
| Risperidone | 1 | 2007 | 383 | 0.060 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2004 | 29 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 1212 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2004 | 8637 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 2085 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2005 | 291 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 431 | 0.050 |
Why?
|
| Acupuncture Therapy | 1 | 2007 | 464 | 0.050 |
Why?
|
| Quinones | 1 | 2002 | 76 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 5867 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 96 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2004 | 3510 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4320 | 0.050 |
Why?
|
| Culture Media | 2 | 1995 | 909 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2007 | 1101 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2004 | 627 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 771 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 693 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 1083 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2005 | 1127 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8316 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 1770 | 0.040 |
Why?
|
| Lymphokines | 1 | 2001 | 948 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2007 | 3391 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 690 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2004 | 3680 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1545 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2001 | 726 | 0.040 |
Why?
|
| Cell Survival | 1 | 2007 | 5881 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2007 | 3492 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 3547 | 0.040 |
Why?
|
| Humans | 18 | 2016 | 743811 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6487 | 0.030 |
Why?
|
| Forecasting | 1 | 2005 | 2950 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 16674 | 0.030 |
Why?
|
| Campylobacter | 1 | 1995 | 59 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 3480 | 0.030 |
Why?
|
| Food Microbiology | 1 | 1995 | 77 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2850 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 2638 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5892 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 3921 | 0.030 |
Why?
|
| Agar | 1 | 1991 | 56 | 0.020 |
Why?
|
| Civil Rights | 1 | 1992 | 132 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3480 | 0.020 |
Why?
|
| Privacy | 1 | 1992 | 238 | 0.020 |
Why?
|
| Organizational Policy | 1 | 1992 | 428 | 0.020 |
Why?
|
| Mice | 2 | 2007 | 81154 | 0.020 |
Why?
|
| Social Responsibility | 1 | 1992 | 388 | 0.020 |
Why?
|
| State Government | 1 | 1992 | 372 | 0.020 |
Why?
|
| Prisoners | 1 | 1992 | 297 | 0.020 |
Why?
|
| Adult | 4 | 2012 | 213889 | 0.020 |
Why?
|
| Prejudice | 1 | 1992 | 569 | 0.020 |
Why?
|
| Animals | 4 | 2007 | 168660 | 0.020 |
Why?
|
| Acute Disease | 2 | 2007 | 7150 | 0.020 |
Why?
|
| Goals | 1 | 1992 | 708 | 0.020 |
Why?
|
| Male | 5 | 2012 | 349776 | 0.020 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2005 | 21 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1991 | 1870 | 0.020 |
Why?
|
| Health Education | 1 | 1992 | 1056 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 215 | 0.010 |
Why?
|
| Middle Aged | 3 | 2012 | 213241 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 758 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2002 | 201 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 23398 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2002 | 319 | 0.010 |
Why?
|
| ras Proteins | 1 | 2005 | 1059 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 29777 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2002 | 434 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 11059 | 0.010 |
Why?
|
| Female | 4 | 2012 | 380020 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 1142 | 0.010 |
Why?
|
| Public Health | 1 | 1992 | 2603 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2007 | 3420 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4749 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 5179 | 0.010 |
Why?
|
| United States | 2 | 2016 | 69859 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2504 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3772 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4221 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1995 | 277 | 0.010 |
Why?
|
| Decision Making | 1 | 2007 | 3887 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2007 | 3207 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4552 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 53250 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3706 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7793 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 63042 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12944 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 15993 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15526 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 10940 | 0.010 |
Why?
|
| Temperature | 1 | 1995 | 2202 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 7908 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 9718 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7719 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5264 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 39001 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1995 | 7172 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 20827 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_